Molecular epidemiology and clinical features of hand, foot and mouth disease requiring hospitalization after the use of enterovirus A71 inactivated vaccine in chengdu, China, 2017-2022: a descriptive study

References

• Ooi MH, Wong SC, Lewthwaite P, et al. Clinical features, diagnosis, and management of enterovirus 71. Lancet Neurol. 2010;9(11):1097–1105.
   PubMed Web of Science ®Google Scholar
• Cox B, Levent F. Hand, foot, and mouth disease. Jama. 2018;320(23):2492.
   PubMedGoogle Scholar
• Viruses ICoTo. ICTV Virus Taxonomy (2021 Release) 2021 [cited 2022 20 July]. Available from: https://talk.ictvonline.org/taxonomy/.
   Google Scholar
• Xing W, Liao Q, Viboud C, et al. Hand, foot, and mouth disease in China, 2008-12: an epidemiological study. Lancet Infect Dis. 2014;14(4):308–318.
   PubMed Web of Science ®Google Scholar
• Puenpa J, Wanlapakorn N, Vongpunsawad S, et al. The history of enterovirus A71 outbreaks and molecular epidemiology in the Asia-pacific region. J Biomed Sci. 2019;26(1):75.
   PubMed Web of Science ®Google Scholar
• Li Y, Chang Z, Wu P, et al. Emerging enteroviruses causing hand, foot and mouth disease, China, 2010-2016. Emerging Infect Dis. 2018;24(10):1902–1906.
   PubMed Web of Science ®Google Scholar
• Zhao TS, Du J, Sun DP, et al. A review and meta-analysis of the epidemiology and clinical presentation of coxsackievirus A6 causing hand-foot-mouth disease in China and global implications. Rev Med Virol. 2020 Mar;30(2):e2087.
   PubMed Web of Science ®Google Scholar
• Cabrerizo M, Tarragó D, Muñoz-Almagro C, et al. Molecular epidemiology of enterovirus 71, coxsackievirus A16 and A6 associated with hand, foot and mouth disease in Spain. Clin Microbiol Infect. 2014;20(3):O150–O156.
   PubMed Web of Science ®Google Scholar
• Fu X, Wan Z, Li Y, et al. National epidemiology and evolutionary history of four hand, foot and mouth disease-related enteroviruses in China from 2008 to 2016. Virol Sin. 2020;35(1):21–33.
   PubMed Web of Science ®Google Scholar
• Huang CC, Liu CC, Chang YC, et al. Neurologic complications in children with enterovirus 71 infection. N Engl J Med. 1999;341(13):936–942.
   PubMed Web of Science ®Google Scholar
• Teoh HL, Mohammad SS, Britton PN, et al. Clinical characteristics and functional motor outcomes of enterovirus 71 neurological disease in children. JAMA Neurol. 2016;73(3):300–307.
   PubMed Web of Science ®Google Scholar
• Mao QY, Wang Y, Bian L, et al. EV71 vaccine, a new tool to control outbreaks of hand, foot and mouth disease (HFMD). Expert Rev Vaccines. 2016;15(5):599–606.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Li JX, Jin PF, et al. Enterovirus 71: a whole virion inactivated enterovirus 71 vaccine. Expert Rev Vaccines. 2016;15(7):803–813.
   PubMed Web of Science ®Google Scholar
• Wang J, Jiang L, Zhang C, et al. The changes in the epidemiology of hand, foot, and mouth disease after the introduction of the EV-A71 vaccine. Vaccine. 2021;39(25):3319–3323.
   PubMed Web of Science ®Google Scholar
• Prevention CCfDCa. Overview of the National Epidemic of Notifiable Infectious Diseases in China (2021) 2022 [cited 2022 11th, May]. Available from: http://www.nhc.gov.cn/jkj/s3578/202204/4fd88a291d914abf8f7a91f6333567e1.shtml.
   Google Scholar
• Xiaoli W, Hongxin W, Lei J, et al. Summary of research in economic burden of hand, foot, and mouth disease in China (in Chinese) [review]. Chin J Epidemiol. 2020;41(02):273–279.
   Google Scholar
• Wang J, Teng Z, Cui X, et al. MALDI-TOF MS for identification oftsukamurellaspecies:tsukamurella tyrosinosolvensas the predominant species associated with ocular infections. Emerg Microbes Infect. 2018;7(1):1.
   PubMedGoogle Scholar
• Gao L, Zou G, Liao Q, et al. Spectrum of enterovirus serotypes causing uncomplicated hand, foot, and mouth disease and enteroviral diagnostic yield of different clinical samples. Clin Infect Dis 2018;67(11):1729–1735.
   PubMed Web of Science ®Google Scholar
• Ai Y, Zhang W, Wu J, et al. Molecular epidemiology and clinical features of enteroviruses-associated hand, foot, and mouth disease and herpangina outbreak in zunyi, China, 2019. Front Med (Lausanne). 2021;8:656699.
   PubMed Web of Science ®Google Scholar
• Jiang H, Zhang Z, Rao Q, et al. The epidemiological characteristics of enterovirus infection before and after the use of enterovirus 71 inactivated vaccine in kunming, China. Emerg Microbes Infect. 2021;10(1):619–628.
   PubMed Web of Science ®Google Scholar
• Li XW, Ni X, Qian SY, et al. Chinese guidelines for the diagnosis and treatment of hand, foot and mouth disease (2018 edition). World J Pediatr. 2018;14(5):437–447.
   PubMed Web of Science ®Google Scholar
• Patrick Giraudoux ORCID iD [aut c, Jean-Philippe Antonietti [ctb], Colin Beale [ctb], Renaud Lancelot [ctb], David Pleydell [ctb], Mike Treglia [ctb]. pgirmess: Spatial Analysis and Data Mining for Field Ecologists (Version 2.0.0) 2022 [updated February 23, 2022; cited 2022 June 21]. Available from: https://cran.r-project.org/web/packages/pgirmess/pgirmess.pdf.
   Google Scholar
• Head JR, Collender PA, Lewnard JA, et al. Early evidence of inactivated enterovirus 71 vaccine impact against hand, foot, and mouth disease in a major center of ongoing transmission in China, 2011-2018: A longitudinal surveillance study. Clin Infect Dis 2020;71(12):3088–3095.
   PubMed Web of Science ®Google Scholar
• Xinhua. Hand, foot and mouth disease on rise in Beijing Beijing2018 [cited 2022 20th June]. Available from: http://www.chinadaily.com.cn/a/201807/04/WS5b3c6e64a3103349141e0a93.html.
   Google Scholar
• Han Y, Chen Z, Zheng K, et al. Epidemiology of hand, foot, and mouth disease before and after the introduction of enterovirus 71 vaccines in chengdu, China, 2009-2018. Pediatr Infect Dis J. 2020;39(10):969–978.
   PubMed Web of Science ®Google Scholar
• Sun X, Xu Y, Zhu Y, et al. Impact of non-pharmaceutical interventions on the incidences of vaccine-preventable diseases during the COVID-19 pandemic in the eastern of China. Hum Vaccin Immunother. 2021;17(11):4083–4089.
   PubMed Web of Science ®Google Scholar
• Yang B, Liu F, Liao Q, et al. Epidemiology of hand, foot and mouth disease in China, 2008 to 2015 prior to the introduction of EV-A71 vaccine. Euro Surveill. 2017 Dec;22(50.
   Google Scholar
• Qiu J, Yan H, Cheng N, et al. The clinical and epidemiological study of children with hand, foot, and mouth disease in hunan, China from 2013 to 2017. Sci Rep. 2019;9(1):11662.
   PubMedGoogle Scholar
• Liu SL, Pan H, Liu P, et al. Comparative epidemiology and virology of fatal and nonfatal cases of hand, foot and mouth disease in mainland China from 2008 to 2014. Rev Med Virol 2015;25(2):115–128.
   PubMed Web of Science ®Google Scholar
• Linsuwanon P, Puenpa J, Huang SW, et al. Epidemiology and seroepidemiology of human enterovirus 71 among Thai populations. J Biomed Sci 2014;21(1):16.
   PubMedGoogle Scholar
• Ji H, Fan H, Lu PX, et al. Surveillance for severe hand, foot, and mouth disease from 2009 to 2015 in Jiangsu province: epidemiology, etiology, and disease burden. BMC Infect Dis 2019;19(1):79.
   PubMedGoogle Scholar
• Wang YR, Sun LL, Xiao WL, et al. Epidemiology and clinical characteristics of hand foot, and mouth disease in a shenzhen sentinel hospital from 2009 to 2011. BMC Infect Dis 2013;13:539.
   PubMed Web of Science ®Google Scholar
• Hu L, Maimaiti H, Zhou L, et al. Changing serotypes of hand, foot and mouth disease in Shanghai, 2017-2019. Gut Pathog. 2022;14(1):12.
   PubMed Web of Science ®Google Scholar
• Han Z, Song Y, Xiao J, et al. Genetic recombination in fast-spreading coxsackievirus A6 variants: a potential role in evolution and pathogenicity. Virus Evol. 2020;6(2):veaa084.
   PubMed Web of Science ®Google Scholar
• Zhou J, Shi Y, Miao L, et al. Molecular epidemiology and recombination of enterovirus A71 in mainland China from 1987 to 2017. Int Microbiol. 2021;24(3):291–299.
   PubMed Web of Science ®Google Scholar
• Sun H, Gao M, Cui D. Molecular characteristics of the VP1 region of enterovirus 71 strains in China. Gut Pathog. 2020;12:38.
   PubMed Web of Science ®Google Scholar
• Ji T, Han T, Tan X, et al. Surveillance, epidemiology, and pathogen spectrum of hand, foot, and mouth disease in mainland of China from 2008 to 2017. Biosafety and Health. 2019;1(1):32–40.
   Google Scholar
• Song Y, Zhang Y, Ji T, et al. Persistent circulation of coxsackievirus A6 of genotype D3 in mainland of China between 2008 and 2015. Sci Rep. 2017;7(1):5491.
   PubMedGoogle Scholar
• Mirand A, le Sage FV, Pereira B, et al. Ambulatory pediatric surveillance of hand, foot and mouth disease as signal of an outbreak of coxsackievirus A6 infections, France, 2014-2015. Emerging Infect Dis. 2016;22(11):1884–1893.
   PubMed Web of Science ®Google Scholar
• Bian L, Wang Y, Yao X, et al. Coxsackievirus A6: a new emerging pathogen causing hand, foot and mouth disease outbreaks worldwide. Expert Rev Anti Infect Ther. 2015;13(9):1061–1071.
   PubMed Web of Science ®Google Scholar
• Li J, Lin C, Qu M, et al. Excretion of enterovirus 71 in persons infected with hand, foot and mouth disease. Virol J. 2013;10:31.
   PubMed Web of Science ®Google Scholar